Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or…
AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene…
Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune…
What really happens to your cells under stress, in space, and during space travel? In this episode, we zoom in on the physiological, cellular, and molecular levels to uncover how zero gravity affects…
Can we grow new kidneys from stem cells? In this episode, we explore how scientists are using pluripotent stem cells to create kidney organoids that mimic early kidney development. We discuss how…
Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen production, and tissue…
Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow…
Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this…
Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode, we explore how these…
Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to…
